Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, United Kingdom.
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, United Kingdom.
Curr Opin Microbiol. 2014 Feb;17(100):67-74. doi: 10.1016/j.mib.2013.12.002. Epub 2013 Dec 29.
Infection of the gastrointestinal tract is commonly linked to pathological imbalances of the resident microbiota, termed dysbiosis. In recent years, advanced high-throughput genomic approaches have allowed us to examine the microbiota in an unprecedented manner, revealing novel biological insights about infection-associated dysbiosis at the community and individual species levels. A dysbiotic microbiota is typically reduced in taxonomic diversity and metabolic function, and can harbour pathobionts that exacerbate intestinal inflammation or manifest systemic disease. Dysbiosis can also promote pathogen genome evolution, while allowing the pathogens to persist at high density and transmit to new hosts. A deeper understanding of bacterial pathogenicity in the context of the intestinal microbiota should unveil new approaches for developing diagnostics and therapies for enteropathogens.
胃肠道感染通常与常驻微生物群落的病理性失衡有关,这种失衡被称为菌群失调。近年来,先进的高通量基因组方法使我们能够以前所未有的方式研究微生物群落,揭示了感染相关菌群失调在群落和个体物种水平上的新生物学见解。失调的微生物群落通常在分类多样性和代谢功能上减少,并可能含有使肠道炎症恶化或表现出全身疾病的条件致病菌。菌群失调也可以促进病原体基因组的进化,同时使病原体保持高密度并传播给新宿主。在肠道微生物群落的背景下更深入地了解细菌的致病性,应该可以揭示开发肠道病原体诊断和治疗方法的新方法。